Tim Canty MD PLLC
Tim Canty MD PLLC was paid $184K by Medicaid between Jan 2018 and Mar 2023, across 15 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoTIM CANTY MD PLLC
BROOKLYN, NY 11249
BROOKLYN, NY 11249
33aNPI1073899571assigned 10/27/2011
33bProvider typeSpecialist
28Total paid$184K
24GClaims5,594
24DCodes billed15
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#388 of 1,221
Median peer was paid$45K
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 394 | $15K | |
| 2019 | 900 | $31K | |
| 2020 | 918 | $38K | |
| 2021 | 2,177 | $64K | |
| 2022 | 932 | $27K | |
| 2023 | 273 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 2,235 | 1,738 | $87K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 773 | 731 | $46K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13% | 234 | 234 | $23K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 199 | 174 | $8K |
| 72275 | 4.3% | 145 | 129 | $8K | |
| 76942 | 3.7% | 187 | 156 | $7K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 36 | 31 | $2K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 629 | 553 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 660 | 594 | $759.16 |
| 20553 | <1% | 14 | 14 | $458.59 | |
| 20552 | <1% | 13 | 13 | $429.50 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 33 | 28 | $217.00 |
3 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 132 | $23.46 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 39 | $8.18 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 265 | $0.51 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCANTY, TIM (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Interventional Spinal Pain Care PC | New York, NY | $73K |
| NY Ambulatory and Anesthesia PC | New York, NY | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.